2024 Conference Publication Deprescribing and shared decision-making researchScott, Sion, Weir, Kristie Rebecca, Denig, Petra, Ailabouni, Nagham and López-Toribio, María (2024). Deprescribing and shared decision-making research. 12th International Shared Decision Making Conference, Lausanne, Switzerland, 7 - 10 July 2024. London, United Kingdom: BMJ Group. doi: 10.1136/bmjebm-2024-sdc.243 |
2024 Conference Publication Co-designing a consult patient decision aid for deprescribing cholinesterase inhibitorsAilabouni, Nagham J., Thompson, Wade, Hilmer, Sarah N., Lyntara, Q., Uirke Janet, M., Bourke, Qcneece Alice, Furst, Chloe and Reeve, Emily (2024). Co-designing a consult patient decision aid for deprescribing cholinesterase inhibitors. 12th International Shared Decision Making Conference, Lausanne, Switzerland, 7 - 10 July 2024. London, United Kingdom: BMJ Group. doi: 10.1136/bmjebm-2024-sdc.4 |
2023 Conference Publication Co-designing The Prime Tool To Empower People Living With Dementia And Their Carers To Initiate Deprescribing ConversationsShafiee Hanjani, Leila, Weir, Kristie, Reeve, Emily, Brandt, Nicole, Tao, Eric and Ailabouni, Nagham J. (2023). Co-designing The Prime Tool To Empower People Living With Dementia And Their Carers To Initiate Deprescribing Conversations. FIP World Congress, Brisbane, QLD Australia, 24 - 28 September 2023. |
2023 Conference Publication An International Comparison Of Deprescribing Interventional Studies: How To Determine Factors That Contribute To Translational Deprescribing Success?Elsedfy, Youmna, Mangin, Dee, Jamieson, Hamish, Bergler, Ulrich, Nishtala, Prasad, Weaver, Susan K., Reeve, Emily, Freeman, Christopher R. and Ailabouni, Nagham (2023). An International Comparison Of Deprescribing Interventional Studies: How To Determine Factors That Contribute To Translational Deprescribing Success?. FIP World Congress, Brisbane, QLD Australia, 24 - 28 September 2023. |
2023 Conference Publication Top 10 unanswered questions about quality use of medicines in people living with dementiaTan, Edwin, Reeve, Emily, Ailabouni, Nagham, Chenoweth, Lynn, Sawan, Mouna, Nguyen, Tuan Anh, Ellett, Lisa Kalisch, Gilmartin-Thomas, Julia, Sluggett, Janet, Quirke, Lyntara and Hilmer, Sarah (2023). Top 10 unanswered questions about quality use of medicines in people living with dementia. International Social Pharmacy Workshop 2022, Sydney, NSW Australia, 11-14 July 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.sapharm.2023.04.035 |
2023 Conference Publication Preventing gout flares when introducing or escalating urate-lowering therapy: a systematic review and network meta-analysisMaher, Dorsa, Reeve, Emily, Hopkins, Ashley, Tan, Jiun Ming, Tantiongco, Mahsa, Ailabouni, Nagham, Woodman, Richard, Stamp, Lisa, Bursill, David, Proudman, Susanna and Wiese, Michael (2023). Preventing gout flares when introducing or escalating urate-lowering therapy: a systematic review and network meta-analysis. 2023 Australian Rheumatology Association (ARA) 63rd Annual Scientific Meeting, Hobart, TAS, Australia, 6–9 May 2023. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/imj.16057 |
2023 Conference Publication Attitudes of healthcare professional towards the use of parenteral methotrexate in rheumatoid arthritis patients: a qualitative studyMing, Jiun, Reeve, Emily, Chai, Wern Chern, Ailabouni, Nagham, Proudman, Susanna and Wiese, Michael (2023). Attitudes of healthcare professional towards the use of parenteral methotrexate in rheumatoid arthritis patients: a qualitative study. 2023 Australian Rheumatology Association (ARA) 63rd Annual Scientific Meeting, Hobart, TAS, Australia, 6–9 May 2023. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/imj.16057 |
2022 Conference Publication Preventing urate-lowering therapy induced gout flares: a systematic review and network meta-analysisMaher, Dorsa, Reeve, Emily, Tan, Jiun Ming, Tantiongco, Mahsa M., Ailabouni, Nagham J., Hopkins, Ashley M., Woodman, Richard J., Stamp, Lisa, Bursill, David, Proudman, Susanna and Wiese, Michael D. (2022). Preventing urate-lowering therapy induced gout flares: a systematic review and network meta-analysis. APSA-ASCEPT, Perth, WA, Australia, 29 November - 2 December 2022. |
2022 Conference Publication Co-designing deprescribing guidelines’ implementation into hospital for people living with dementiaAilabouni, Nagham J., Weir, Kristie, Maher, Dorsa, Hilmer, Sarah, Koeper, Ivanka, Russell, Patrick, Shakib, Sepehr and Reeve, Emily (2022). Co-designing deprescribing guidelines’ implementation into hospital for people living with dementia. APSA-ASCEPT, Perth, WA Australia, 29 November - 2 December 2022. |
2022 Conference Publication Attitudes of Rheumatoid Arthritis (RA) patients towards Disease Modifying Anti-rheumatic drugs (DMARD) deprescribingMurray, Lauren, Reeve, Emily, Ailabouni, Nagham, Kalisch Ellett, Lisa and Weise, Michael (2022). Attitudes of Rheumatoid Arthritis (RA) patients towards Disease Modifying Anti-rheumatic drugs (DMARD) deprescribing. The Pharmaceutical Society of Australia, Sydney, Australia, 29-31 July 2022. |